Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anaferon for Acute Respiratory Viral Infections
NCT03707912Phase 4Completed
- Sponsor
- Materia Medica Holding
- Start
- Oct 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of anaferon in acute respiratory viral infection (ARVI), sponsored by Materia Medica Holding. Started Oct 2018; status: completed.
02
Drugs
anaferon
03
Conditions
acute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03707912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707912.